The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence.
about
Impact of repeated nicotine and alcohol coexposure on in vitro and in vivo chlorpyrifos dosimetry and cholinesterase inhibitionAdvances in genetic studies of substance abuse in ChinaAbsorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.The hunt for new genes and polymorphisms that can control the response to drugs.Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.Predictors of cessation in African American light smokers enrolled in a bupropion clinical trialProspects, promise and problems on the road to effective vaccines and related therapies for substance abuseHow Resistant to Tampering are Codeine Containing Analgesics on the Market? Assessing the Potential for Opioid Extraction.Inter-gene correlation on oligonucleotide arrays: how much does normalization matter?In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step.Addiction Research Centres and the Nurturing of Creativity. Substance abuse research in a modern health care centre: the case of the Centre for Addiction and Mental Health.Lignes directrices canadiennes sur l’utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse: Résumé clinique pour les médecins de famille. Partie 1: population en général.
P2860
Q23920793-138063E8-3BC6-4D26-B9CF-2DACF6D13A77Q33744466-4D97DE32-5C51-4A38-9641-5C0CC23A758AQ34165511-B4634E62-971C-43B1-A3A6-77FA36B64AE8Q34837113-DEB58720-0B91-4CA7-9899-34C16F05EEE2Q35548497-A4E3CE13-082D-42A2-B339-834E9ECB9DEDQ35828032-98864BB4-05AD-4D92-AE91-48567D7C8438Q36572648-523410CC-F6B7-4CD8-9FB0-906F6006186EQ37082158-85AB8F7D-2A18-42E0-B7E0-E13CFF0F6AB8Q37459006-4D1EBE18-6B30-43D2-B4DA-8EC15718EBFCQ42664210-9746E964-933B-47A2-AE0A-7F891FDD5149Q44777240-0B8EC5D0-BF2E-461C-AC8D-C83882D727FCQ45238388-0F47DD05-BE54-4FE7-85F8-D30F03A00FDEQ45871147-55AF7326-6BF4-4655-9120-2C8789FE975F
P2860
The role of pharmacogenetically-variable cytochrome P450 enzymes in drug abuse and dependence.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The role of pharmacogeneticall ...... in drug abuse and dependence.
@ast
The role of pharmacogeneticall ...... in drug abuse and dependence.
@en
The role of pharmacogeneticall ...... in drug abuse and dependence.
@nl
type
label
The role of pharmacogeneticall ...... in drug abuse and dependence.
@ast
The role of pharmacogeneticall ...... in drug abuse and dependence.
@en
The role of pharmacogeneticall ...... in drug abuse and dependence.
@nl
prefLabel
The role of pharmacogeneticall ...... in drug abuse and dependence.
@ast
The role of pharmacogeneticall ...... in drug abuse and dependence.
@en
The role of pharmacogeneticall ...... in drug abuse and dependence.
@nl
P2860
P356
P1433
P1476
The role of pharmacogeneticall ...... s in drug abuse and dependence
@en
P2093
Lisa A Howard
P2860
P304
P356
10.1517/14622416.3.2.185
P577
2002-03-01T00:00:00Z